ngspik | 1014
NGS Breast Carcinoma (PIK3CA, PTEN, AKT1, ESR1)
Keywords:
AKT1
Alpelisib
Breast Carcinoma
Capivasertib
ESR1
Elacestrant
NGS
Next Generation Sequencing
PIK3CA
PTEN
SERD
Status
| Material |
|
||
|---|---|---|---|
| Hint |
Variants Hotspot: PIK3CA, PTEN, AKT1, ESR1. Liquid biopsy testing is available for ESR1 in particular. To order this analysis, please contact the Customer Service Center: contact@viollier.ch or 0848 121 121.This analysis may result in excess information. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the GUMG shall ensure the patient is informed accordingly (see www.viollier.ch/en/SGMG_consent). Tarification: according to Tarmed. |
||
| Duration | 5 days | ||
| Frequency | 2 x per week | ||
| Method | Next Generation Sequencing |
Price/Rate
| Price |
Price
CHF 0.00
|
|---|---|
| Rate |
Rate
0.00 TP
|